Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by canadafanon Dec 04, 2020 10:11am

380 Views

Post# 32036245

Warning...would not want to be holding short over weekend

The conference is next week. Even without NR, prior, Matt said to expect Aware-1 results at that conference.
Good results , & the top enD moves dramatically.
seeing recent bod insider shares purchases, increased SP activity etc.
evidence looks good.
I would caution anyone shorting, to cover.ASAp
there is a much larger upside potential , than down right now

<< Previous

Bullboard Posts

Next >>

Stockhouse DealRoom opens new Australian opportunities